| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
|
Zarrinkar, Patrick P.
|
|
|
114 |
14 |
p. 2984-2992
|
artikel
|
| 2 |
AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance
|
de Jonge, Hendrik J.M.
|
|
|
114 |
14 |
p. 2869-2877
|
artikel
|
| 3 |
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
|
Haferlach, Claudia
|
|
|
114 |
14 |
p. 3024-3032
|
artikel
|
| 4 |
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
|
Romay-Penabad, Zurina
|
|
|
114 |
14 |
p. 3074-3083
|
artikel
|
| 5 |
Cell adhesion molecule 1: a novel risk factor for venous thrombosis
|
Hasstedt, Sandra J.
|
|
|
114 |
14 |
p. 3084-3091
|
artikel
|
| 6 |
Changelian et al. The specificity of JAK3 kinase inhibitors. Blood. 2008;111(4):2155–2157.
|
|
|
|
114 |
14 |
p. 3132
|
artikel
|
| 7 |
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
|
Eberhard, Yanina
|
|
|
114 |
14 |
p. 3064-3073
|
artikel
|
| 8 |
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology
|
Cushman, Mary
|
|
|
114 |
14 |
p. 2878-2883
|
artikel
|
| 9 |
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease
|
Parmar, Simrit
|
|
|
114 |
14 |
p. 2884-2887
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
114 |
14 |
p. i
|
artikel
|
| 11 |
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker
|
Piaggio, Giovanna
|
|
|
114 |
14 |
p. 3127-3130
|
artikel
|
| 12 |
Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite
|
Buyue, Yang
|
|
|
114 |
14 |
p. 3092-3100
|
artikel
|
| 13 |
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status
|
Silva, Fernando P.G.
|
|
|
114 |
14 |
p. 3001-3007
|
artikel
|
| 14 |
High coagulant factors & venous thrombosis
|
Doggen, Carine J.M.
|
|
|
114 |
14 |
p. 2854-2855
|
artikel
|
| 15 |
High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia
|
Tang, Ruoping
|
|
|
114 |
14 |
p. 2993-3000
|
artikel
|
| 16 |
Howell-Jolly body–like inclusions in neutrophils
|
|
|
|
114 |
14 |
p. 2860
|
artikel
|
| 17 |
Hryniewicz et al. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood. 2006;108(12):3834–3842.
|
|
|
|
114 |
14 |
p. 3132
|
artikel
|
| 18 |
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease
|
Nishiwaki, Satoshi
|
|
|
114 |
14 |
p. 3113-3116
|
artikel
|
| 19 |
In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm
|
Lambert, Jonathan R.
|
|
|
114 |
14 |
p. 3018-3023
|
artikel
|
| 20 |
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
|
Gupta, Mamta
|
|
|
114 |
14 |
p. 2926-2935
|
artikel
|
| 21 |
Inhibition of the SDF-1α–CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice
|
Kawaguchi, Akira
|
|
|
114 |
14 |
p. 2961-2968
|
artikel
|
| 22 |
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
|
Choi, Yeon-Sook
|
|
|
114 |
14 |
p. 3117-3126
|
artikel
|
| 23 |
Lack of specific γ-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
|
Burns, William R.
|
|
|
114 |
14 |
p. 2888-2899
|
artikel
|
| 24 |
Lyn and PKCδ order SHIP1 embargo
|
Naik, Ulhas P.
|
|
|
114 |
14 |
p. 2856-2857
|
artikel
|
| 25 |
Lyn, PKC-δ, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion
|
Chari, Ramya
|
|
|
114 |
14 |
p. 3056-3063
|
artikel
|
| 26 |
Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility
|
Zhang, Ke
|
|
|
114 |
14 |
p. 2952-2960
|
artikel
|
| 27 |
Molecular profiling of CD3−CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways
|
Ravoet, Marie
|
|
|
114 |
14 |
p. 2969-2983
|
artikel
|
| 28 |
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
|
Wilcox, Ryan A.
|
|
|
114 |
14 |
p. 2936-2944
|
artikel
|
| 29 |
Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1
|
Skokowa, Julia
|
|
|
114 |
14 |
p. 3044-3051
|
artikel
|
| 30 |
Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab
|
Ambrose, Lyn R.
|
|
|
114 |
14 |
p. 3052-3055
|
artikel
|
| 31 |
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
|
Yi, Tangsheng
|
|
|
114 |
14 |
p. 3101-3112
|
artikel
|
| 32 |
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
|
Navarro, Alfons
|
|
|
114 |
14 |
p. 2945-2951
|
artikel
|
| 33 |
Rho GTPase Cdc42 is essential for B-lymphocyte development and activation
|
Guo, Fukun
|
|
|
114 |
14 |
p. 2909-2916
|
artikel
|
| 34 |
Role of leukemia cell invadosome in extramedullary infiltration
|
Stefanidakis, Michael
|
|
|
114 |
14 |
p. 3008-3017
|
artikel
|
| 35 |
Same mutation, different allele
|
Aichberger, Karl J.
|
|
|
114 |
14 |
p. 2853-2854
|
artikel
|
| 36 |
Screens, iron, and leukemia
|
Stone, Richard M.
|
|
|
114 |
14 |
p. 2857-2858
|
artikel
|
| 37 |
Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines
|
Hayashida, Kazutaka
|
|
|
114 |
14 |
p. 3033-3043
|
artikel
|
| 38 |
T cells helping GVHD: take-away lessons
|
Fowler, Daniel
|
|
|
114 |
14 |
p. 2858-2859
|
artikel
|
| 39 |
The hidden (and lazy) TCR
|
Bonini, Chiara
|
|
|
114 |
14 |
p. 2855-2856
|
artikel
|
| 40 |
The level of monocyte turnover predicts disease progression in the macaque model of AIDS
|
Hasegawa, Atsuhiko
|
|
|
114 |
14 |
p. 2917-2925
|
artikel
|
| 41 |
Vascular complications after splenectomy for hematologic disorders
|
Crary, Shelley E.
|
|
|
114 |
14 |
p. 2861-2868
|
artikel
|
| 42 |
Wiskott-Aldrich syndrome protein is an effector of Kit signaling
|
Mani, Maheswaran
|
|
|
114 |
14 |
p. 2900-2908
|
artikel
|
| 43 |
Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813.
|
|
|
|
114 |
14 |
p. 3131
|
artikel
|
Tijdschrift beschrijving